Abstract:Our study has revealed the increased expression of ZKSCAN3 in several PaCa cell lines. Furthermore, it has demonstrated that controlling ZKSCAN3 expression can regulate the progression of PaCa through autophagy. Therefore, the regulation of autophagy via ZKSCAN3 suggests a potential novel therapeutic target for PaCa. Elevated autophagy activity enhances the malignancy of pancreatic cancer (PaCa), and autophagy is recognized as a novel therapeutic target. Zinc finger protein with KRAB and SCAN domains 3 (ZKSCAN3) is a transcription factor that suppresses autophagy, but its association with PaCa is unknown. We analyzed the function of ZKSCAN3 in PaCa and investigated whether autophagy regulation through ZKSCAN3 could become a new therapeutic target for PaCa. Using reverse transcription‐quantitative polymerase chain reaction and western blotting, we observed that ZKSCAN3 expression was upregulated in several PaCa cell lines compared with normal pancreatic ductal epithelial cells. Additionally, comparing ZKSCAN3 expression with the prognosis of PaCa patients using web databases, we found that higher ZKSCAN3 expression in PaCa was associated with extended overall survival. Knocking down ZKSCAN3 promoted the proliferation of PaCa cells. Moreover, following ZKSCAN3 knockdown, PaCa cells exhibited significantly enhanced migratory and invasive properties. Conversely, overexpression of ZKSCAN3 significantly suppressed the proliferation, migration and invasion of PaCa cells. Additionally, the knockdown of ZKSCAN3 increased the expression of LC3‐II, a marker of autophagy, whereas ZKSCAN3 overexpression decreased LC3‐II expression. In a xenograft mouse model, tumors formed by MIA PaCa‐2 cells in which ZKSCAN3 was knocked down significantly increased in size compared with the control group. In conclusion, ZKSCAN3 expression was upregulated in several pancreatic cancer cells. Additionally, it was revealed that ZKSCAN3 is negatively correlated with the malignancy of PaCa through autophagy. These results suggest that autophagy regulation via ZKSCAN3 may be a new therapeutic target for PaCa.

Epigenetic silencing ZSCAN23 promotes pancreatic cancer growth by activating Wnt signaling

LINC00346 Promotes Pancreatic Cancer Progression Through the CTCF-mediated Myc Transcription

Long Non-Coding RNA DSCAM-AS1 Promotes Pancreatic Cancer Progression Via Regulating the Mir-136-5p/pbx3 Axis

Abstract 1821: LINC00346 Regulates C-Myc Transcriptional Activity Through CTCF in Pancreatic Cancer

Methyl-CpG-binding Protein 2 Drives the Furin/TGF-β1/Smad Axis to Promote Epithelial–mesenchymal Transition in Pancreatic Cancer Cells

MeCP2 suppresses LIN28A expression via binding to its methylated-CpG islands in pancreatic cancer cells.

Over‐expression of FoxM1 Leads to Epithelial–mesenchymal Transition and Cancer Stem Cell Phenotype in Pancreatic Cancer Cells

Single-cell Transcriptome Reveals the Heterogeneity of Malignant Ductal Cells and the Prognostic Value of REG4 and SPINK1 in Primary Pancreatic Ductal Adenocarcinoma

Down-regulation of microRNA-23a promotes pancreatic ductal adenocarcinoma initiation and progression by up-regulation of FOXM1 expression

MicroRNA-23a promotes pancreatic cancer metastasis by targeting epithelial splicing regulator protein 1.

DEPDC1B promotes migration and invasion in pancreatic ductal adenocarcinoma by activating the Akt/GSK3/Snail pathway

A novel epigenetic CREB‐miR‐373 axis mediates ZIP4‐induced pancreatic cancer growth

ZMAT1 acts as a tumor suppressor in pancreatic ductal adenocarcinoma by inducing SIRT3/p53 signaling pathway

Data from Snail Recruits Ring1B to Mediate Transcriptional Repression and Cell Migration in Pancreatic Cancer Cells

The scRNA-sequencing landscape of pancreatic ductal adenocarcinoma revealed distinct cell populations associated with tumor initiation and progression

Expression of ZKSCAN3 protein suppresses proliferation, migration, and invasion of pancreatic cancer through autophagy

Mir-615-5p is Epigenetically Inactivated and Functions As a Tumor Suppressor in Pancreatic Ductal Adenocarcinoma

ZKSCAN5 Activates LAPTM5 Expression by Recruiting SETD7 to Promote Metastasis in Pancreatic Ductal Adenocarcinoma.

SDCBP promotes pancreatic cancer progression by preventing YAP1 from β-TrCP-mediated proteasomal degradation

Ezh2 Promotes Cell Migration And Invasion But Not Alters Cell Proliferation By Suppressing E-Cadherin, Partly Through Association With Malat-1 In Pancreatic Cancer

SUMO-specific protease 1 regulates pancreatic cancer cell proliferation and invasion by targeting MMP-9